title: The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat.
abstract: The neuropeptide Y (NPY) has been suggested to act as a major regulator of emotional processes and body weight. The full spectrum of biological effects of this peptide is mediated by at least four classes of receptors known as the Y(1), Y(2), Y(4), and Y(5) subtypes. However, the respective contribution of each of these receptor subtypes, especially the Y(5) subtype, in emotional processes is still mostly unknown. In the present study, we investigated the effect of long term administration of a selective Y(5) agonist [cPP(1-7),NPY(19-23),Ala(31),Aib(32),Gln(34)]hPP on emotional processes and body weight using two rat models of emotional dysfunctions, the corticosterone (CORT)-induced anxiety model as well as the olfactory bulbectomized (OBX) model of depression and anxiety in Wistar and Sprague-Dawley rats, respectively. The sub-chronic administration of the Y(5) agonist reversed the high levels of locomotion, rearing and grooming in the open field test and the impaired social activity induced by OBX, while increased the percentage of entries and time in the open arm of the elevated plus maze in CORT-treated rats. Furthermore, this Y(5) agonist increased body weight in both strains of control rats. These data further demonstrate that Y(5) receptors are not only involved in the control of body weight but also mediate emotional processing under challenged conditions. Thus, the pharmacotherapeutic administration of a Y(5) agonist could be considered as a potentially novel strategy to alleviate some forms of anxiety and depression in humans.
authors.affiliation: Dept. of Neurology & Neurosurgery, McGill University, Montreal, Canada.
authors.forename: J C
authors.initials: JC
authors.lastname: Morales-Medina
authors.forename: S
authors.initials: S
authors.lastname: Dominguez-Lopez
authors.forename: G
authors.initials: G
authors.lastname: Gobbi
authors.forename: A G
authors.initials: AG
authors.lastname: Beck-Sickinger
authors.forename: R
authors.initials: R
authors.lastname: Quirion
mesh_terms: D055011:Ablation Techniques / Q000379:methods; D000704:Analysis of Variance; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001835:Body Weight / Q000187:drug effects*; D003345:Corticosterone / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems; D004644:Emotions / Q000187:drug effects*; D005106:Exploratory Behavior / Q000187:drug effects; D046353:Immobility Response, Tonic / Q000187:drug effects; D007398:Interpersonal Relations; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D009478:Neuropeptide Y / Q000819:agonists / Q000031:analogs & derivatives*; D009830:Olfactory Bulb / Q000601:surgery; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D017476:Receptors, Neuropeptide Y / Q000819:agonists*; D013550:Swimming / Q000523:psychology
chemical_list: D000893:Anti-Inflammatory Agents; D009478:Neuropeptide Y; D010446:Peptide Fragments; D017476:Receptors, Neuropeptide Y; C100568:neuropeptide Y5 receptor; D003345:Corticosterone